We are live on ! Find out more
BIND

BIND THERAPEUTICS INC
BIND

Delisted

BIND was delisted on the 29th of July, 2016.

Back to rankings

40 hedge funds and large institutions have $37.4M invested in BIND THERAPEUTICS INC in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less funds holding

Funds holding: 43 → 40 (-3)

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

36% less capital invested

Capital invested by funds: $58.4M → $37.4M (-$21M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

57% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 14

Holders
40
Holders Change
-3
Holders Change %
-6.98%
% of All Funds
1.16%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
9
Increased
6
Reduced
14
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$2.7M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$642K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$434K
4
HLA
Hamilton Lane Advisors
Pennsylvania
+$360K
5
BCM
Bridgeway Capital Management
Texas
+$332K

Top Sellers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
-$3.22M
2
BI
BVF Inc
California
-$1.53M
3
Northern Trust
Northern Trust
Illinois
-$699K
4
OM
Opaleye Management
Massachusetts
-$414K
5
PP
Paloma Partners
Connecticut
-$299K
Name Holding Trade Value Shares
Change 		Change in
Stake
PVMCV
1
Polaris Venture Management Co V
Massachusetts
$17.3M – – –
OM
2
Opaleye Management
Massachusetts
$3.87M -$414K -42,000 -9%
Franklin Resources
3
Franklin Resources
California
$3.11M – – –
Principal Financial Group
4
Principal Financial Group
Iowa
$2.61M -$4.69K -476 -0.2%
DM
5
Deerfield Management
New York
$2.35M +$2.7M +274,000 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$1.54M +$434K +44,065 +33%
RPAM
7
Rhenman & Partners Asset Management
Sweden
$932K – – –
BA
8
BlackRock Advisors
Delaware
$866K -$273K -27,647 -22%
CS
9
Credit Suisse
Switzerland
$689K +$326K +33,062 +70%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$559K +$642K +65,125 New
Millennium Management
11
Millennium Management
New York
$496K -$2.93K -297 -0.5%
HLA
12
Hamilton Lane Advisors
Pennsylvania
$314K +$360K +36,500 New
BCM
13
Bridgeway Capital Management
Texas
$290K +$332K +33,717 New
RJA
14
Raymond James & Associates
Florida
$276K -$61.5K -6,240 -16%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$246K -$197 -20 -0.1%
California Public Employees Retirement System
16
California Public Employees Retirement System
California
$227K – – –
TDC
17
Thompson Davis & Co
Virginia
$210K -$62.4K -6,325 -21%
SIM
18
SSI Investment Management
California
$197K -$139K -14,080 -38%
TC
19
TFS Capital
Pennsylvania
$176K +$202K +20,529 New
AP
20
AlpInvest Partners
Netherlands
$163K +$187K +18,923 New
PCM
21
Prelude Capital Management
New York
$137K – – –
VKH
22
Virtu KCG Holdings
New York
$136K +$156K +15,808 New
BPC
23
Banque Pictet & Cie
Switzerland
$135K -$4.43K -449 -3%
BIT
24
BlackRock Institutional Trust
California
$131K – – –
BFA
25
BlackRock Fund Advisors
California
$130K -$10.7K -1,088 -7%
1
2 3

BIND Hedge Fund Activity: Q3 2014 in Review

40 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in BIND THERAPEUTICS INC (BIND) for Q3 2014, worth a combined $37.4M — down 36% from $58.4M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of BIND and 9 opened new positions — a net loss of 3 holders — while 14 trimmed existing stakes and 6 added.

The largest buyer was Deerfield Management, opening a new position worth an estimated $2.7M. The largest seller was Putnam Investments, exiting entirely with an estimated $3.22M sold.

  • 40 institutional investors held BIND THERAPEUTICS INC (BIND) as of Q3 2014, down from 43 in Q2 2014.
  • Funds reported $37.4M of BIND THERAPEUTICS INC stock for Q3 2014, down 36% quarter-over-quarter.
  • 9 funds opened new BIND THERAPEUTICS INC positions in Q3 2014 and 12 closed out, a net change of -3 holders.
  • The largest BIND THERAPEUTICS INC buyer in Q3 2014 was Deerfield Management, an estimated $2.7M added.
  • The largest BIND THERAPEUTICS INC seller in Q3 2014 was Putnam Investments, an estimated $3.22M sold.

Based on aggregated 13F filings for Q3 2014.